Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILENT TECHNOLOGIES, INC.

(A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Agilent Technologies : Announces Target Enrichment Manufacturing Facility in China

08/03/2021 | 08:03am EDT

Agilent Technologies Inc. (NYSE: A) today announced that it has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China.

Agilent is a leading provider of next-generation sequencing assays, and customers often develop custom panels for their routine applications. Therefore, delivery turnaround time is an essential aspect of how Agilent uniquely serves its customers, enabling them to validate and implement their assays quickly and efficiently.

Expanding manufacturing capabilities for SureSelect assays in China, at the same high-quality standard (ISO 13485:2016) as Agilent's U.S.-based manufacturing sites, will significantly reduce the time from initial design to customer delivery. In addition, China-based manufacturing will provide faster development and iteration on custom panel optimization and more rapid supply for routine sequencing applications.

'Agilent's investment in developing and expanding our manufacturing capabilities for SureSelect products represents an example of our commitment to continuous improvement and the growth opportunities we foresee in the China market,' said Kevin Meldrum, vice president and general manager for Agilent's Genomics Division. 'This investment in China ensures that our customers there will have ready access to our assay technology as a local partner that can meet their unique needs.

As a company, Agilent has a long track record of investing in the China market. This announcement extends and reinforces the company's commitment to China, genomics, and our NGS portfolio by embracing and adapting to local market needs.

Disclaimer

Agilent Technologies Inc. published this content on 03 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2021 12:02:04 UTC.


ę Publicnow 2021
All news about AGILENT TECHNOLOGIES, INC.
09/22AGILENT TECHNOLOGIES : Keeps Quarterly Cash Dividend Stable at $0.194 a Share, Payable Oct..
MT
09/22AGILENT TECHNOLOGIES : Announces Cash Dividend of 19.4 Cents per Share
BU
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/17AGILENT TECHNOLOGIES : Cowen Adjusts Price Target for Agilent Technologies to $200 From $1..
MT
09/10RareCyte, Inc. announced that it has received $24.046147 million in funding from Arbore..
CI
09/09RareCyte, Inc. announced that it has received $24 million in funding from Arboretum Ven..
CI
09/07AGILENT TECHNOLOGIES : Announces Thought Leader Award to David R. Liu at the Broad Institu..
PU
09/02AGILENT TECHNOLOGIES : and Visiopharm Expand Collaboration with Worldwide Distribution Agr..
BU
09/02Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
CI
09/01AGILENT TECHNOLOGIES : to Present at Wells Fargo Virtual Healthcare Conference
BU
More news
Analyst Recommendations on AGILENT TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 6 318 M - -
Net income 2021 1 075 M - -
Net Debt 2021 1 485 M - -
P/E ratio 2021 49,4x
Yield 2021 0,44%
Capitalization 52 201 M 52 201 M -
EV / Sales 2021 8,50x
EV / Sales 2022 7,94x
Nbr of Employees 16 700
Free-Float 99,7%
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | A | US00846U1016 | MarketScreener
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 172,44 $
Average target price 173,73 $
Spread / Average Target 0,75%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Koh Boon Hwee Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
AGILENT TECHNOLOGIES, INC.45.53%52 201
THERMO FISHER SCIENTIFIC28.18%238 660
DANAHER CORPORATION46.17%231 396
INTUITIVE SURGICAL, INC.25.71%122 378
SIEMENS HEALTHINEERS AG40.16%77 521
EDWARDS LIFESCIENCES CORPORATION29.89%74 587